Smartlab Europe

Business & Industry

Is US Planning Executive Order on Chinese Pharma Companies?

It is worth noting that the pharmaceutical sector’s recent source of novel molecules may as well be coming under threat. Apparently, it is the White House which is reportedly preparing an executive order that is going to place restrictions...

Pharma Cold Chain Workforce Competency Frameworks

Building Excellence Through Structured Competency Development The pharmaceutical cold chain industry demands highly skilled professionals who can manage complex temperature-controlled systems while ensuring regulatory compliance and product integrity. Competency frameworks provide structured approaches to developing, assessing, and maintaining the skills...

Pharma Supply Chain and Customs Clearance Solutions

The Critical Challenge of Pharmaceutical Customs Clearance The pharmaceutical industry faces unprecedented challenges in global supply chain management, particularly when navigating the complex landscape of international customs clearance for clinical trial materials and commercial drug batches. Customs delays can have...

Optimizing DMF Quality for Successful Health Authority Filings

A Drug Master File (DMF) is a confidential regulatory submission that provides comprehensive, precise, and accurate data about an Active Pharmaceutical Ingredient (API) or a Finished Product Dosage Form (FP). It encompasses critical information on the manufacturing process, quality...

Cook Medical Says Extra Tariff to Be Passed to US Customers

According to medical device firm Cook Medical, the costs associated with the tariff policy of Donald Trump will, wherever possible, get passed onto the US customers. This happens to be as per the directors at one of the largest employers...

Er-Kim Announces Exclusive Agreement with CNX Therapeutics to Distribute Oncology Products Across CEE and Turkey

Partnership will broaden portfolio distribution of oncology products to cancer patients in the specified regions Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, today announced a distribution agreement with CNX Therapeutics to supply selected oncology products across Central...

Chinese Pharmaceutical Firms Turn to Local Reagent Suppliers

The Chinese pharmaceutical firms are increasingly looking out for the local reagent suppliers so as to cut the costs as well as delivery times. Growing import tariffs because of the US-China trade war, as well as concerns with regard...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »